. 2002 Dec;161(6):2179–2193. doi: 10.1016/s0002-9440(10)64495-1

Table 1.

Effects of Lisinopril on Urinary Protein Levels, Intraglomerular Protein and Inflammatory Cell Accumulation, α-SMA Expression, and Glomerulosclerosis

Group	Proteinuria (mg/day)	IgG (score)	C3 (score)	Alb (score)	ED-1	OX-6 (MHC 11)	α-SMA (score)	Glomerulosclerosis (%)
Group	Proteinuria (mg/day)	IgG (score)	C3 (score)	Alb (score)	(cells/glom section)		α-SMA (score)	Glomerulosclerosis (%)
30-day RMR	225 ± 89^*	1.30 ± 0.34^*	0.73 ± 0.18^*	1.80 ± 0.38^*	12.51 ± 2.73^*	12.09 ± 4.04^*	1.16 ± 0.46^*	18.9 ± 9.5^*
30-day RMR+ lisinopril	28 ± 8^†	0.36 ± 0.35^†	0.18 ± 0.17^†	0.30 ± 0.20^†	7.20 ± 1.65^†	5.96 ± 1.77^†	0.34 ± 0.26^†	1.5 ± 2.3^†
30-day control	27 ± 5	0.26 ± 0.12	0.03 ± 0.05	0.19 ± 0.07	2.93 ± 0.70	3.09 ± 0.87	0	1.05 ± 0.8

*, P < 0.01 versus control;

^†, P < 0.01 versus RMR at 30 days.